YAZEED ALBALAWI

Dr. YAZEED ALBALAWI


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2024 in Medical Sciences
Verified
Journal Article
Open access
PDF file
BABadriah Alanazi
Badriah Alanazi
G. MuhiuddinG. Muhiuddin
G. Muhiuddin
YAYAZEED ALBALAWI
YAZEED ALBALAWI
KAKhalid of Alhazmi
Khalid of Alhazmi
OAOthman Alzahrani
Othman Alzahrani
MZMOHAMMAD ZUBAIR
MOHAMMAD ZUBAIR
The increasing prevalence of antibiotic resistance, driven by the production of extended-spectrum beta-lactamases (ESBLs), presents a critical challenge to current medical treatments, particularly in clinical settings. Understanding the distribution and frequency of ESBL-producing bacteria is essential for developing effective control strategies. This study investigated the antibiotic resistance and extended-spectrum beta-lactamase (ESBL) production in bacterial isolates in clinical and non-clinical (food) specimens in Tabuk, KSA. A total of 57 bacterial isolates were analysed, with E. coli and Pseudomonas sp. being the most prevalent. High resistance rates were observed, particularly against third-generation cephalosporins in clinical isolates. ESBL screening revealed a significant prevalence in clinical samples (58.3%), with E. coli showing the highest positivity. Conversely, only a low percentage of food isolates were ESBL positive. Molecular analysis confirmed the presence of various ESBL genes, with blaCTX-M being the most frequent, predominantly found in clinical isolates. This study highlights the concerning levels of antibiotic resistance and ESBL production in the region, emphasising the need for effective infection control measures and prudent antibiotic use.

1 January 2024 in Clinical Cancer Investigation Journal
Verified
Journal Article
Open access
PDF file
YAYAZEED ALBALAWI
YAZEED ALBALAWI
Data availability regarding gynecological malignancies is essential for policymaking and future planning. No researchers have assessed the prevalence of gynecological cancer in Tabuk, Saudi Arabia. We aimed to assess the same in Tabuk, Saudi Arabia. retrospective study was conducted in King Fahd Specialists Hospital in Tabuk City, KSA, from November 2023 to February 2024. The hospital was randomly chosen from the four central hospitals in Tabuk City. All the records of adult women who were diagn